A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer
N Mitin, KA Nyrop, SL Strum, A Knecht, LA Carey… - NPJ breast …, 2022 - nature.com
Identifying patients at higher risk of chemotherapy-induced peripheral neuropathy (CIPN) is
a major unmet need given its high incidence, persistence, and detrimental effect on quality …
a major unmet need given its high incidence, persistence, and detrimental effect on quality …
Determining the mechanisms of long-term pain in childhood cancer survivorship
T Valentine - 2023 - irep.ntu.ac.uk
Chemotherapy-induced peripheral neuropathy (CIPN) commonly occurs following platinum-
based chemotherapy (eg cisplatin). Neonatal exposure to cisplatin results in a delayed but …
based chemotherapy (eg cisplatin). Neonatal exposure to cisplatin results in a delayed but …